Skip to content
Disclosery

13F-HR filed by DC Funds, LP

DC Funds, LP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-14, with 3 holding rows worth $3,693,338.

Accession
0001398344-23-003141
Filer
CIK 1869028
Filed
2023-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2022

A combination report, 3 entries on the cover page, a total value of $3,693,338 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,693,338 with VALUE read as dollars as filed, 13F file number 028-21338. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
BARINTHUS BIOTHERAPEUTICS PL91864C107ADS642,204$1,509,179dollars as filed
WEREWOLF THERAPEUTICS INC95075A107CMN589,102$1,207,659dollars as filed
Tscan Therapeutics Inc89854M101COM630,000$976,500dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001398344-23-003141this filing2023-02-14acceptance time not in the bulk data set